Duragesic is a powerful narcotic pain reliever used to treat severe and chronic pain. It is often prescribed when other medications are not effective or when the pain becomes too intense for other types of medications. When Duragesic is prescribed, it is important to understand how it works, its side effects, and the potential risks associated with it. This article will provide an overview of Duragesic, including what it is, how it works, potential side effects and risks, and more. We’ll also discuss alternatives to Duragesic that may be more appropriate for some patients. With this information in hand, you can make an informed decision about whether or not Duragesic is right for you or your loved one.
Duragesic is a brand name for the opioid pain medication fentanyl. It is a strong narcotic pain reliever that is used to treat moderate to severe pain. Duragesic is available in a patch form and as a lozenge. The patch is applied to the skin and delivers a steady amount of medication over a period of 72 hours. The lozenge is dissolved in the mouth and works more quickly than the patch but only lasts for about 30 minutes.
Fentanyl works by binding to opioid receptors in the brain and spinal cord where it blocks pain signals from reaching the brain. It also reduces the amount of oxygen that reaches the brain, which can lead to drowsiness, confusion, and slowed breathing. Duragesic should only be used by people who are already taking other opioid medications for pain relief and are tolerant to their effects.
When used as directed, Duragesic works by replacing the missing opioids in your body. By providing a continuous, low-level dose of an opioid medication, it can help to reduce cravings and alleviate withdrawal symptoms. It is important to note that Duragesic is not a substitute for other forms of treatment, such as counseling or therapy.
Duragesic is a transdermal patch, which means it is applied directly to the skin. The medication is then slowly released over time and absorbed through the skin into the bloodstream. This allows for a slow and steady release of medication that can help to manage pain while avoiding peaks and valleys in opioid levels in the body.
Like any medication, Duragesic carries the risk of side effects. The most common side effects include:
-Dizziness
-Sleepiness
-Nausea and vomiting
-Constipation
-Dry mouth
Less common side effects include:
-Allergic reactions (rash, hives, itching, difficulty breathing)
-Anxiety or agitation
-Chest pain or irregular heartbeat
-Confusion or hallucinations
-Depression
-Fainting or lightheadedness
-Seizures
Duragesic is a powerful long-acting opioid medication that can provide relief for moderate to severe chronic pain. It works by binding to the opioid receptors in your brain, which reduces the perception of pain and increases feelings of calmness and relaxation. While Duragesic can be incredibly helpful in managing pain, it comes with its own set of risks and side effects that must be taken into consideration before taking this medication.
1.
What is Mohs micrographic surgery? 8 FAQs about Mohs
2.
The Higher the Disability Burden From Disease, the Higher the Suicide Risk
3.
Older Men Increasingly Overtreated for Prostate Cancer, Study Suggests
4.
Anticoagulation for 12 months has been found to improve outcomes in cancer patients with minor blood clots.
5.
Addition of regional nodal irradiation does not decrease rates of invasive breast cancer recurrence, study finds
1.
Biomimetic Nanovesicles for Breast Cancer: Targeting Senescence to Overcome Chemoresistance
2.
Essential Oncology Updates: Diagnosis, Treatment Advances, Tools & Education Resources
3.
Enhancing Cancer Care: From Diagnosis Through Survivorship and Beyond
4.
Omentum Cancer: Causes, Symptoms, and Treatment Options
5.
Acrochordon: What It Is, Causes, And How To Manage This Skin Condition
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
4.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation